S024 Advocacy in Dermatology with the Experts: Intersections to Safeguard the Specialty
DESCRIPTION
This session will provide an overview of the intersections of advocacy and dermatology from national experts. Diverse content will highlight applications of science, legislation, administrative and judicial policy, and other sociopolitical events to regulation and innovation within the specialty. Speakers will emphasize opportunities to engage with advocacy across the professional continuum. Topics include augmented intelligence, reimbursement and scope of practice, preservation of the patient-physician relationship, climate change, regulatory landscape, health equity, and organized medicine. Speakers will offer engagement tips for advocacy across the professional continuum and how to augment dermatology's voice in local, state, national, and international societies.
LEARNING OBJECTIVES
Describe the role of advocacy in the practice of dermatology, patient care, mitigation of intersectional health disparities and inequity, and the broader advancement of the specialty. List examples of the ways in which advocacy at multiple levels has moved the specialty forward and is poised to do so in the future.
Identify opportunities for engagement with advocacy across the training, professional, and practice continuum.
Discuss novel areas of advocacy focus within dermatology and outline potential ways to spearhead advocacy efforts both at the individual and institutional grassroots levels and through local, regional, national, and international organized medicine.
SCHEDULE
9:00 AM
Symposium Introduction
Klint Peebles, MD, FAAD
9:05 AM
Dermatology and Advocacy in the House of Medicine
Jack S. Resneck Jr., MD, FAAD
9:25 AM
Climate Advocacy in Dermatology: Protecting Skin Health and Equity in a Warming World
Eva R. Parker, MD, FAAD
9:50 AM
Ensuring We Don't "Fly-Over" Opportunities
Mary E. Logue, MD, FAAD
10:10 AM
Preserving the Patient-Physician Relationship: Leading through Advocacy
Klint Peebles, MD, FAAD
10:30 AM
Healthcare Finance, Reform, and Data Derm
Marta Jane Van Beek, MD, MPH, FAAD
10:50 AM
2026 Scope of Practice Update
Aliya Courtney Hines, MD, PhD, FAAD
11:15 AM
Augmented Intelligence: What's New and Where are We Headed?
Jenna C Lester, MD, FAAD
11:35 AM
Q&A and Panel Discussion
DIRECTOR
Klint Peebles, MD, FAAD
SPEAKERS
Aliya Courtney Hines, MD, PhD, FAAD
Mary E. Logue, MD, FAAD
Eva R. Parker, MD, FAAD
Jack S. Resneck Jr., MD, FAAD
Marta Jane Van Beek, MD, MPH, FAAD
DISCLOSURES
Aliya Courtney Hines, MD, PhD, FAAD
Functional Fluidics – Founder(Stock);
Mary E. Logue, MD, FAAD
Eli Lilly and Company – Consultant (1099 relationship)(Fees);
Eva R. Parker, MD, FAAD
L'Oreal – Advisory Board(Honoraria), Speaker(Honoraria);
Klint Peebles, MD, FAAD
Kaiser Permanente – Employee(Salary);
Jack S. Resneck Jr., MD, FAAD
No financial relationships exist with ineligible companies.
Marta Jane Van Beek, MD, MPH, FAAD
No financial relationships exist with ineligible companies.